Medical Technology

Non-active implantable devices

Diseases of the nervous system / neurology

Oxford Endovascular Limited is a medical device company developing a next generation flow-diverter for the minimally invasive treatment of intracranial aneurysms preventing death or disability due to brain haemorrhage.

Biotechnology - R&D Services

Cell culture, Proteomics

OET Ltd is a biotechnology company, active in Baculovirus protein expression. The core technology, flashBACTM is a one step high throughput Baculovirus based protein expression platform which enables fast and simultaneous production of multiple recombinant viruses suitable for small and large protein expression systems.

Biotechnology - R&D Services

Diagnostic services, Genomics

Neoplasms / cancer / oncology, Congenital malformations, deformations and chromosomal abnormalities / medical genetics

OGT, a Sysmex Group company, is a global provider of clinical and diagnostic genomic solutions that are created for scientists by scientists - including CytoCell®, CytoSure® and SureSeq ranges of FISH, microarray and NGS products. The company is dedicated to creating products that enable researchers and clinical decision makers to reach the right care decisions for each patient, every time.

Professional Services and Consulting

Business development, Financial services, Management consulting, Property management/Real estate

Oxford Innovation Ltd. operates and manages a network of business and innovation centers in the United Kingdom. The company offers office and lab spaces, virtual offices, new centers, and meeting spaces for small and medium businesses, as well as property management solutions for building owners.

Biotechnology - R&D Services

Analytical services, Diagnostic services

Oxford Molecular Biosensors Ltd. offers products and services based in whole-cell biosensor technology; sensing cells able to detect toxicity, heavy metals, antibiotics, etc. The company operates from a molecular microbiology laboratory. The company offer testing of various samples including rivers, lakes, industrial and domestic wastewaters to provide insights into their biology and chemistry.

Biotechnology - R&D Services

Diagnostic instrumentation

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology, Diseases of the nervous system / neurology

Oxford Nanoimaging Ltd (ONI) is a biotechnology company specializing in super-resolution microscopy. Their flagship product, the Nanoimager, is a desktop-sized microscope that enables researchers to visualize and track individual molecules in living cells with 20nm resolution. ONI aims to democratize super-resolution microscopy by making it more accessible and affordable for researchers.

Biotechnology - R&D Services

Diagnostic instrumentation, Diagnostic services, Genomics

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology

Oxford Nanopore Technologies Limited has developed a new generation of sensing technology that uses nanopores - nano-scale holes - embedded in high-tech electronics, to perform comprehensive molecular analyses. The GridION™ system and miniaturized MinION™ device are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows, and direct analysis of the molecule of interest.

Professional Services and Consulting

Property management/Real estate

Oxford North is a project led by Thomas White Oxford, a company wholly owned by St John's College, Oxford. Oxford North will be a new global life sciences innovation district for Oxford, with sustainability at its heart, providing: 4,500 new jobs, 480 new and affordable homes for circa 1,500 people, small shops, bars and restaurants, hotel, circa 23 acres of open spaces including three new parks, and significant investment into the walking, cycling, bus and highway networks. Oxford North will contribute circa £150 million per year in GVA to the economy.

Investor

Oxford Science Enterprises (OSE) is an independent, billion-pound investment company to found, fund and build transformational businesses via its unique partnership with the University of Oxford, the world’s #1 research university. This partnership enables OSE to work with the brightest academic minds tackling the world’s toughest challenges and guarantees unrivalled access to their scientific research. In collaboration with its global network of entrepreneurs and advisers, OSE goes well beyond funding to shape and nurture these complex ideas into successful businesses. Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, and Deep Tech – the company adopts a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience. To date, OSE has invested £0.5 billion in over 80 ambitious companies built on Oxford science.

Supplier & Engineering

Distributors

Oxford Seating designs and manufactures seating and related furniture for all aspects of the working lives. The company provides seating and furniture solutions to leading companies in many different industries from corporate business environments to pharmaceutical and electronics manufacturing to laboratory, hospital and other healthcare establishments and also educational, industrial and retail environments.

Medical Technology

Biomaterials, Non-active implantable devices

Skin and subcutaneous tissue / dermatology

Oxford Silk Phage Technologies Ltd. is a biotechnology company focused on developing bacteriophage-based solutions to combat bacterial infections, particularly those caused by antibiotic-resistant pathogens. The company combines phage therapy with advanced biomaterials, including silk-based delivery systems, to create targeted antimicrobial treatments for medical and healthcare applications. Its research aims to provide effective alternatives to conventional antibiotics while improving the precision and safety of infection management.

Biotechnology - R&D Services

Analytical services, Cell culture, CRO (Contract Research Organization)

Oxford StemTech is a UK-based biotechnology company that specialises in induced pluripotent stem cell (iPSC) technology for biomedical research and drug discovery. The company develops scalable stem cell reprogramming platforms, human disease models, organoids and assembloids to support disease modelling, drug discovery and precision medicine. Its services also include cell line characterisation, quality control, cellular differentiation and drug screening.

Professional Services and Consulting

Technology transfer

Oxford University Innovation Limited is wholly owned by the University of Oxford. The company's mission is to be an international technology transfer organization, to transfer technology and expertise from the University of Oxford, to deliver value to all clients, and to maximise social and economic benefits in a commercial manner.

Biotechnology - Therapeutics and Diagnostics

Peptides, Vaccines

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology

Oxford Vacmedix UK Limited is a biotechnology company that employs its proprietary Recombinant Overlapping Peptides (ROP) platform to create therapeutic vaccines and diagnostic tests that elicit broad, multi-epitope T-cell responses. Its development efforts focus mainly on oncology, with lead vaccine candidates OVM-100 and OVM-200, while the same technology is also being applied to infectious diseases, including COVID-19.

Biotechnology - R&D Services

Analytical services, CRO (Contract Research Organization), Screening

Particology Ltd is a contract research organization which specializes in the production of active ingredient synthesis and product formulation. The company also offers services such as crystallization, particle engineering, solid state chemistry, materials characterization, and formulation. The company's services are used in the areas of pharmaceutical, agrochemical, cosmetic, veterinary medicine, and nutraceutical industries.

Professional Services and Consulting

Other

Partners& is an operator of an insurance advisory firm based in High Wycombe, United Kingdom. The company provides bespoke insurance advice in the fields of risk management, employee benefits, business insurance and family & home for corporates, individuals and families tailored as per client's needs.

Biotechnology - R&D Services

Analytical services, CMO (Contract Manufacturing Organization)

Patheon Pharma Services is a provider of pharmaceutical development and manufacturing services. The company supports pharmaceutical and biotechnology clients in bringing their products to market, from formulation development to commercial-scale manufacturing. Patheon's goal is to deliver compliant pharmaceutical products and services that meet the evolving needs of its clients and their patients.

Biotechnology - Therapeutics and Diagnostics

Small molecules

Neoplasms / cancer / oncology

Pathios is a drug discovery and development company focused on translating innovative science into new medicines. The company is focused on developing small-molecule inhibitors of the pH-sensing G protein-coupled receptor GPR65 to target immunosuppressive macrophages in advanced cancers.

Professional Services and Consulting

Management consulting, Drug development consulting

PCS BIOTECH LTD is engaged in engineering-related scientific and technical consulting activities. The company also offers research and experimental development activities on biotechnology.

Biotechnology - R&D Services

Other

Pencil Biosciences Limited developes gene-editing technology designed to create a range of applications like new therapeutic options for patients with rare diseases. The company's technology develops a novel genome modulation platform that helps to anticipate a wide impact across a range of applications, enabling medical professionals to overcome the challenges of gene editing associated with various technologies.